Feng, B., Liu, J., Ma, T., Cai, Z., Zhang, S., Yang, X., Song, H., Cai, G., Xu, X., Zhong, H., Yu, M., Abuduaini, N., Jiang, L., Wang, X., Wang, W. (2025). Total neoadjuvant therapy with FOLFOX plus bevacizumab and short-course radiotherapy for Ras mutant, high-risk, locally advanced rectal cancer: The TRAINER trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.133